Dis-Chem Pharmacies Ltd. said surging demand for GLP-1 medicines is helping drive double-digit growth in its dispensary revenue as South Africans increasingly turn to the expensive drugs used to treat diabetes and obesity.
Dis-Chem Pharmacies Ltd. said surging demand for GLP-1 medicines is helping drive double-digit growth in its dispensary revenue as South Africans increasingly turn to the expensive drugs used to treat diabetes and obesity.
<iframe src="https://statesidedaily.com/embed/cluster/a3b4acfadec5cc8aa37102e4dbf8443827365eb5" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="GLP-1 Demand Boosts Dis-Chem’s South Africa Pharmacy Revenue"></iframe>